Author:
Uchida Takahiro,Hazekawa Mai,Yoshida Miyako,Matsumoto Kunio,Sakai Yoshiki
Publisher
Japanese Pharmacological Society
Subject
Pharmacology,Molecular Medicine
Reference53 articles.
1. 1 Tanouchi T, Kawamura M, Ohyama I, Kajiwara I, Iguchi Y, Okada T, et al. Highly selective inhibitors of thromboxane synthetase. 2 Pyridine derivatives. J Med Chem. 1981;24:1149–1155.
2. 2 Kataoka M, Nagaya N, Satoh T, Itoh T, Murakami S, Iwase T, et al. A long-acting prostacyclin agonist with thromboxane inhibitory activity for pulmonary hypertension. Am J Respir Crit Care Med. 2005;172:1575–1580.
3. 3 Obata H, Sakai Y, Ohnishi S, Takeshita S, Mori H, Kodama M, et al. Single injection of a sustained-release prostacyclin analog improves pulmonary hypertension in rats. Am J Respir Crit Care Med. 2008;177:195–201.
4. 4 Murakami S, Nagaya N, Itoh T, Kataoka M, Iwase T, Horio T, et al. Prostacyclin agonist with thromboxane synthase inhibitory activity (ONO-1301) attenuates bleomycin-induced pulmonary fibrosis in mice. Am J Physiol Lung Cell Mol Physiol. 2006;290:59–65.
5. 5 Nakamura K, Sata M, Iwata H, Sakai Y, Hirata Y, Kugiyama K, et al. A synthetic small molecule, ONO-1301, enhances endogenous growth factor expression and augments angiogenesis in the ischemic heart. Clin Sci. 2007;112:607–616.
Cited by
15 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献